SERIAL CHANGES OF PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY IN THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - COMPARISON BETWEEN THROMBOLYTIC THERAPIES WITH MUTANT TPA (LANOTEPLASE BMS-200980) AND RECOMBINANT TPA (ALTEPLASE)/
N. Ogata et al., SERIAL CHANGES OF PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY IN THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - COMPARISON BETWEEN THROMBOLYTIC THERAPIES WITH MUTANT TPA (LANOTEPLASE BMS-200980) AND RECOMBINANT TPA (ALTEPLASE)/, Circulation, 94(8), 1996, pp. 514-514